NSB — Neuroscientific Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$21.82m
- AU$17.28m
- AU$0.63m
Australia Stock Exchange release from NEUROSCIENTIFIC : Results of Meeting
Australia Stock Exchange release from NEUROSCIENTIFIC : Chairman's Address to Shareholders
Australia's NeuroScientific Biopharmaceuticals rises on R&D contract
Brief: Neuroscientific Biopharmaceuticals Partners With International Cro Biospective For Multiple Sclerosis Studies
Australia Stock Exchange release from NEUROSCIENTIFIC : NSB Partners with Biospective for MS Studies
Australia Stock Exchange release from NEUROSCIENTIFIC : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 18:49:53
Australia Stock Exchange release from NEUROSCIENTIFIC : Company Presentation - updated
Australia Stock Exchange release from NEUROSCIENTIFIC : Company Presentation
Australia Stock Exchange release from NEUROSCIENTIFIC : Completion of Safety Pharmacology Studies
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 09:53:24
Australia Stock Exchange release from NEUROSCIENTIFIC : Proposed issue of securities - NSB
Australia Stock Exchange release from NEUROSCIENTIFIC : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from NEUROSCIENTIFIC : Date of AGM & Closing Date for Director Nominations
Australia Stock Exchange release from NEUROSCIENTIFIC : Broker Briefing Investor Webinar
Australia Stock Exchange release from NEUROSCIENTIFIC : Investor Webinar
Australia Stock Exchange release from NEUROSCIENTIFIC : Company Presentation
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 09:16:07
Australia Stock Exchange release from NEUROSCIENTIFIC : NSB Receives R&D Advance & Overseas Finding